I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rishipathak, Deepali
24
results:
Search for persons
X
Format
Online (24)
Mediatypes
Articles (Online) (6)
OpenAccess-fulltext (18)
Sorted by: Relevance
Sorted by: Year
?
1
Immunomodulatory effects and improved outcomes with cisplat..:
Galsky, Matthew D.
;
Guan, Xiangnan
;
Rishipathak, Deepali
...
Cell Reports Medicine. 5 (2024) 2 - p. 101393 , 2024
Link:
https://doi.org/10.1016/..
?
2
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to..:
Huseni, Mahrukh A.
;
Wang, Lifen
;
Klementowicz, Joanna E.
...
Cell Reports Medicine. 4 (2023) 1 - p. 100878 , 2023
Link:
https://doi.org/10.1016/..
?
3
A Phase 1b/2 Study of Atezolizumab with or Without Bacille ..:
Inman, Brant A.
;
Hahn, Noah M.
;
Stratton, Kelly
...
European Urology Oncology. 6 (2023) 3 - p. 313-320 , 2023
Link:
https://doi.org/10.1016/..
?
4
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris III, Howard A.
;
de Miguel Luken, Maria J.
...
Clinical Cancer Research. 28 (2022) 16 - p. 3452-3463 , 2022
Link:
https://doi.org/10.1158/..
?
5
Single-cell analysis reveals clonally expanded tumor-associ..:
Fehlings, Michael
;
Kim, Leesun
;
Guan, Xiangnan
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 8 - p. e004759 , 2022
Link:
https://doi.org/10.1136/..
?
6
Author Correction: High systemic and tumor-associated IL-8 ..:
Yuen, Kobe C.
;
Liu, Li-Fen
;
Gupta, Vinita
...
Nature Medicine. 27 (2021) 3 - p. 560-560 , 2021
Link:
https://doi.org/10.1038/..
?
7
CD8(+) T cell-intrinsic IL-6 signaling promotes resistance ..:
Huseni, Mahrukh A
;
Wang, Lifen
;
Klementowicz, Joanna E
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873827/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae
;
Burris, Howard
;
de Miguel Luken, Maria
...
qt6b1472nt. , 2022
Link:
https://escholarship.org..
?
9
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris, Howard A
;
de Miguel Luken, Maria J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662912/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
10
Single-cell analysis reveals clonally expanded tumor-associ..:
Fehlings, Michael
;
Kim, Leesun
;
Guan, Xiangnan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394212/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris, Howard A
;
Luken, Maria J. de Miguel
...
Clinical Cancer Research, Vol.28 No.16, pp.3452-3463. , 2022
Link:
https://hdl.handle.net/1..
?
12
High systemic and tumor-associated IL8 correlates with redu..:
Yuen, Kobe C
;
Liu, Lifen
;
Gupta, Vinita
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286544/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
13
Supplementary Table S4 from Atezolizumab plus Magrolimab, N..:
Alexandra Drakaki
;
Thomas Powles
;
Aristotelis Bamias
...
doi:10.1158/1078-0432.24473260.v1. , 2023
Link:
https://doi.org/10.1158/..
?
14
Supplementary Figure S4 from Atezolizumab plus Magrolimab, ..:
Alexandra Drakaki
;
Thomas Powles
;
Aristotelis Bamias
...
doi:10.1158/1078-0432.24473272.v1. , 2023
Link:
https://doi.org/10.1158/..
?
15
Supplementary Figure S1 from Atezolizumab plus Magrolimab, ..:
Alexandra Drakaki
;
Thomas Powles
;
Aristotelis Bamias
...
doi:10.1158/1078-0432.24473281.v1. , 2023
Link:
https://doi.org/10.1158/..
1-15